(Q50120617)

25 February 2018

title

Cefditoren activity against nearly 1000 non-fastidious bacterial isolates and the development of in vitro susceptibility test methods. (English)

1 reference

25 February 2018

1 reference

1

Jones RN

1 reference

25 February 2018

author name string

Biedenbach DJ

series ordinal

2

1 reference

25 February 2018

Johnson DM

series ordinal

3

1 reference

25 February 2018

publication date

1 June 2000

1 reference

25 February 2018

Diagnostic Microbiology and Infectious Disease

published in

1 reference

25 February 2018

volume

37

1 reference

25 February 2018

issue

2

1 reference

25 February 2018

page(s)

143-146

1 reference

25 February 2018

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900135-8

7 January 2021

In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900135-8

7 January 2021

Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900135-8

7 January 2021

Inoculum effect and bactericidal activity of cefditoren and other antibiotics against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900135-8

7 January 2021

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900135-8

7 January 2021

In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900135-8

7 January 2021

10.1016/S0732-8893(00)00135-8

Identifiers

DOI

1 reference

25 February 2018

release_hvum553zufgktfvvpcvu4rrfhm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hvum553zufgktfvvpcvu4rrfhm

24 November 2022

mapped directly with Wikidata item

PubMed ID

10863109

1 reference

25 February 2018